Jenny J. Zhang

Ms. Zhang has extensive experience representing both patentees and patent challengers in all phases of litigation. Past matters include representing:

• A global healthcare company in ITC investigation and related district court litigation over pre-filled syringe technology for intravitreal injection;
• Teva in Hatch-Waxman litigation related to a generic version of a drug product for the treatment of ADHD;
• E. & J. Gallo Winery in patent litigation related to variable rate irrigation technology;
• A small technology company in theft of trade secret litigation in California state court against a former employee.
• Fresenius Kabi in inter partes review proceedings involving patents on purification processes for proteins expressed in non-mammalian systems;
• Celltrion in parallel BPCIA patent infringement and inter partes review proceedings involving Celltrion’s proposed biosimilar to the oncology drug, Herceptin® (trastuzumab);
• Actavis at trial over patents in the District of New Jersey related to an oral solid dosage form of the opioid receptor antagonist drug, Relistor® (methylnaltrexone);
• Actavis in Hatch-Waxman litigation brought by AstraZeneca in the District of Delaware involving the cardiovascular drug, Brilinta® (ticagrelor);
• Teva at trial in litigation against five generic manufacturers involving patents directed to the treatment of multiple sclerosis with a new dosing regimen for Copaxone® (glatiramer acetate);
• West-Ward Pharmaceuticals in litigation brought by Hospira in the District of Delaware related to the sedative drug, Precedex® (dexmedetomidine);
• Multiple biologic and biosimilar manufacturers in various non-public representations, including pre-suit investigations and arbitration proceedings;
• A startup founder in proceedings to remove state court dispute to federal court by asserting patent counterclaims related to rights over metal alloy technology;
• A small business patentee in litigation in the Eastern District of Texas over digital rights management technology; 

PRO BONO

Ms. Zhang maintains an active pro bono practice, representing individual and organization clients in both civil and criminal proceedings on a wide range of issues. Her practice has included:

• Successfully challenging, on First Amendment grounds, an anti-panhandling ordinance enacted by the City of Lowell, MA on behalf of homeless residents, McLaughlin v. City of Lowell (D. Mass.);
• Winning a preliminary injunction, on Eighth Amendment and ADA grounds, against a prison’s denial of methadone treatment to an inmate recovering from opioid use disorder, Pesce v. Coppinger (D. Mass.); Preparing a trial defense for indigent former healthcare insurance executive facing multiple federal healthcare fraud and identity theft charges, U.S. v. Brettschneider (D. Mass.);
• Co-authoring a cert-stage amicus brief on behalf of CATO Institute and Florida Association of Criminal Defense Lawyers challenging the Eleventh Circuit’s interpretation of the harmless-error standard in criminal cases, Pon v. United States;
• Co-authoring a cert-stage amicus brief on behalf of coalition of minority veterans organizations challenging the constitutionality of sex-based Selective Service registration requirement, National Coalition for Men v. Selective Service System;
• Co-authoring petition for rehearing en banc on Fourth Amendment inevitable discovery doctrine in criminal appeal, U.S. v. Raymond Bullette (4th Cir.);
• Co-authoring amicus brief on behalf of National Women’s Law Center defending constitutionality of the Affordable Care Act, Texas v. United States (5th Cir.);
• Co-authoring amicus brief on behalf of World Professional Association for Transgender Health challenging constitutionality of North Carolina’s public restrooms law, Carcano v. Cooper (4th Cir.).